HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

China trials new HIV vaccine on humans

China which has 840,000 people with HIV, a conservative estimate say experts, will carry out the very first trials of a new virus on human guinea pigs.

13 Mar 2005

Biologists discover why 10% of Europeans are safe from HIV infection

Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-Ä32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavia and relatively low levels in areas bordering the Mediterranean.

9 Mar 2005

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

A public clinic offering antiretroviral (ARV) treatment to people with HIV/AIDS, recently established in Botswana, has had its share of trials and errors.

9 Mar 2005

Study examines consequences of Thailand's "War on Drugs"

Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand’s aggressive war on illicit drugs and the war’s impact on injection drug users.

9 Mar 2005

HIV is not an independent risk factor for severe heart disease

Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).

8 Mar 2005

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

The nation’s frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

8 Mar 2005

AIDS drug pricing complaint in South Africa against GlaxoSmithKline moves forward

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed following an order late last week by South Africa's Competition Tribunal that will allow the complaint to go forward.

8 Mar 2005

New system for growing human embryonic stem cells could make therapies utilising the cells safer for patients

A new system for growing human embryonic stem cells could make therapies utilising the cells safer for patients, concludes a study published online by The Lancet (Tuesday, March 8, 2005).

8 Mar 2005

HIV virus removed from fathers sperm

27 babies in Japan have been born virus-free after the virus was removed from the the sperm of HIV-positive fathers.

7 Mar 2005

Two chemicals boost immune cells' ability to fight HIV without gene therapy

A UCLA AIDS Institute study has discovered that two chemical compounds may help the immune systems of HIV-infected persons fight the disease without invasive gene therapy.

7 Mar 2005

Risky injection behaviors are established at the onset of injection drug use

The circumstances surrounding the first injection experience of young injection drug users are significantly linked to future injection behavior, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.

7 Mar 2005

Study looks at the ability of some monkey species to resist developing AIDS

The Tulane National Primate Research Center received a five-year grant of more than $2 million from the National Institute of Allergy and Infectious Diseases to study the ability of some monkey species to resist developing AIDS.

7 Mar 2005

HIV patients at risk of exhausting treatment options

A small but growing proportion of HIV infected patients in the United Kingdom may be in danger of exhausting current treatment options, says a paper published online by the BMJ today.

6 Mar 2005

HIV testing should be widely accepted, without conventional voluntary counselling and testing

HIV testing should no longer be accorded any special status, argue two senior doctors in this week's BMJ.

6 Mar 2005

90 million Africans with AIDS predicted

In a study, entitled Aids in Africa, compiled over two years, using over 150 experts, the UN predicts that nearly 90 million Africans could be infected in the next 20 years if the epidemic is not combated. Some 25 million Africans have HIV.

5 Mar 2005

Government is treating the symptoms and not fighting the causes of infectious diseases

The Microbiology Awareness Campaign gathered momentum this week at the House of Lords when scientists informed Peers and MPs that new and re-emerging infectious diseases could spell trouble if not tackled soon.

3 Mar 2005

Lancet neonatal survival series

Three million of the four million newborn babies who die worldwide each year could be saved by low-tech and low-cost interventions, concludes a landmark series of articles published online by The Lancet (Thursday March 3, 2005).

3 Mar 2005

HAART saves 2 million life years

The total impact of HIV treatment in the US has been evaluated for the first time. Dr. Rochelle Walensky, ( Harvard Medical School in Boston), speaking at the 12th Annual Retrovirus Conference, quoted from research which estimated the survival benefits of highly active antiretroviral therapy (HAART) and opportunistic infection prophylaxis in the US from 1989 to 2003.

2 Mar 2005

Information hub on HIV, hep C

The University of New South Wales (UNSW) is hosting the first online database in the country that houses the latest information relating to HIV, hepatitis C and certain other diseases.

1 Mar 2005

Molecule from South American tree Quillaja, helps battle disease

The first synthesis of QS-21A, a medicinally important molecule that helps the body battle disease, has been achieved by chemists at the University of Illinois at Urbana-Champaign.

1 Mar 2005